Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 3
2013 2
2015 7
2016 3
2017 1
2018 2
2019 5
2020 3
2021 5
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Parra RS, Chebli JMF, de Azevedo MFC, Chebli LA, Zabot GP, Cassol OS, de Sá Brito Fróes R, Santana GO, Lubini M, Magro DO, Imbrizi M, Moraes ACDS, Teixeira FV, Alves Junior AJT, Gasparetti Junior NLT, da Costa Ferreira S, Queiroz NSF, Kotze PG, Féres O. Parra RS, et al. Among authors: teixeira fv. Crohns Colitis 360. 2024 Apr 11;6(2):otae023. doi: 10.1093/crocol/otae023. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38681979 Free PMC article.
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study.
de Souza LR, Magro DO, Teixeira FV, Parra RS, Miranda EF, Féres O, Saad-Hossne R, Soares Prates Herrerias G, Nisihara RM, Coy CSR, Sassaki LY, Kotze PG. de Souza LR, et al. Among authors: teixeira fv. Pharmaceutics. 2023 Feb 9;15(2):586. doi: 10.3390/pharmaceutics15020586. Pharmaceutics. 2023. PMID: 36839908 Free PMC article.
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.
Perin RL, Magro DO, Andrade AR, Argollo M, Carvalho NS, Damião AOMC, Dotti AZ, Ferreira SDC, Flores C, Ludvig JC, Nones RB, Queiroz NSF, Parra RS, Steinwurz F, Teixeira FV, Kotze PG. Perin RL, et al. Among authors: teixeira fv. Crohns Colitis 360. 2022 Dec 19;5(1):otac050. doi: 10.1093/crocol/otac050. eCollection 2023 Jan. Crohns Colitis 360. 2022. PMID: 36777366 Free PMC article.
Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB).
Sassaki LY, Magro DO, Saad-Hossne R, Baima JP, Flores C, Correia LM, Celani LMS, De Abreu Ferrari ML, Zacharias P, Feitosa MR, Dos Santos CHM, De Freitas Lins Neto MA, Quaresma AB, De Lima Junior SF, De Vasconcelos GBS, Cassol OS, Dos Santos Pinto A, Kurachi G, Goncalves Filho FA, Gasparini RG, Furlan TK, Catapani WR, Coy CSR, De Souza Menegassi V, Colombo MM, Fróes RSB, Teixeira FV, Moraes AC, Santana GO, Parente JML, Vilela EG, Queiroz NSF, Kotze PG; GEDIIB (Brazilian Study Group of IBD). Sassaki LY, et al. Among authors: teixeira fv. BMC Gastroenterol. 2022 May 29;22(1):268. doi: 10.1186/s12876-022-02341-7. BMC Gastroenterol. 2022. PMID: 35644668 Free PMC article.
Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB).
Romero RK, Magro DO, Queiroz NSF, Damião AOMC, Teixeira FV, Nones RB, Sassaki LY, Saad-Hossne R, Kotze PG. Romero RK, et al. Among authors: teixeira fv. Gastroenterol Hepatol. 2022 Aug-Sep;45(7):499-506. doi: 10.1016/j.gastrohep.2021.09.005. Epub 2021 Oct 8. Gastroenterol Hepatol. 2022. PMID: 34634427 English, Spanish.
Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.
Garcia KS, Facas BP, Machado MB, Teixeira FV, Avedano L, Lönnfors S, Hossne RS, Peyrin-Biroulet L, Queiroz NSF. Garcia KS, et al. Among authors: teixeira fv. Therap Adv Gastroenterol. 2021 May 18;14:17562848211013249. doi: 10.1177/17562848211013249. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34046083 Free PMC article.
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
Queiroz NSF, Teixeira FV, Freire CCF, Motta MP, Vasconcellos MAM, Chebli LA, Saad-Hossne R; Brazilian Inflamatory Bowel Diseases Study Group (GEDIIB) COVID taskforce. Queiroz NSF, et al. Among authors: teixeira fv. Arq Gastroenterol. 2021 Jan-Mar;58(1):1-4. doi: 10.1590/S0004-2803.202100000-02. Arq Gastroenterol. 2021. PMID: 33909805 Free article.
Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey.
Queiroz NSF, Teixeira FV, Motta MP, Chebli LA, Hino AAF, Martins CA, Quaresma AB, da Silva AAP, Damião AOMC, Saad-Hossne R, Kotze PG. Queiroz NSF, et al. Among authors: teixeira fv. World J Gastroenterol. 2021 Mar 28;27(12):1226-1239. doi: 10.3748/wjg.v27.i12.1226. World J Gastroenterol. 2021. PMID: 33828396 Free PMC article.
32 results